Literature DB >> 17712750

Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure.

Thomas Bénet1, Marie-Christine Nicolle, Anne Thiebaut, Marie-Antoinette Piens, Franck-Emmanuel Nicolini, Xavier Thomas, Stéphane Picot, Mauricette Michallet, Philippe Vanhems.   

Abstract

BACKGROUND: The objective of the study was to assess the impact of the relocation of an adult hematological intensive care unit on invasive aspergillosis (IA) incidence.
METHODS: A quasi-experimental study, including a control group and an intervention group that both underwent pretest and posttest evaluations, was conducted in the 3 adult hematological intensive care units (each composed of 14 single rooms) in a university hospital from 14 April 2005 through 1 February 2006. One of these units was relocated from the main building to an adjoining modular construction. In this unit, 4 rooms were equipped with laminar airflow before relocation; all rooms were equipped with positive pressure isolation after relocation. The 2 other units (control group), each containing 8 rooms with laminar airflow, did not undergo environmental modification. The diagnostic criteria for IA were based on the criteria of the European Organization for Research and Treatment of Cancer.
RESULTS: In total, 356 hospitalized patients were included. Of the 21 cases of IA, 18 were nosocomial, and 3 were of undetermined origin. In the relocated unit, the incidence of IA decreased from 13.2% (9 patients) before relocation to 1.6% (1 patient) after relocation (P=.018). Eight of the 9 patients with IA before relocation stayed in rooms without specific air treatment. The rate of IA did not change in the control group. Patient characteristics were similar in each unit before and after relocation.
CONCLUSION: We detected a straightforward association between environmental modification and decreased IA incidence, which emphasizes the use of an environmental strategy, including high-efficiency air filtration, in the prevention of IA.

Entities:  

Mesh:

Year:  2007        PMID: 17712750     DOI: 10.1086/521378

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis.

Authors:  Jesús Guinea; Darío García de Viedma; Teresa Peláez; Pilar Escribano; Patricia Muñoz; Jacques F Meis; Corné H W Klaassen; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

3.  Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients.

Authors:  Michael Loschi; Caroline Thill; Christian Gray; Marion David; Marie-France Bagatha; Ali Chamseddine; Nathalie Contentin; Fabrice Jardin; Helene Lanic; Emilie Lemasle; Pascal Lenain; Aspasia Stamatoullas; Hervé Tilly; Stephane Lepretre
Journal:  Mycopathologia       Date:  2015-01-31       Impact factor: 2.574

4.  Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009.

Authors:  Marie-Christine Nicolle; Thomas Bénet; Anne Thiebaut; Anne-Lise Bienvenu; Nicolas Voirin; Antoine Duclos; Mohamad Sobh; Giovanna Cannas; Xavier Thomas; Frank-Emmanuel Nicolini; Frédérique De Monbrison; Marie-Antoinette Piens; Stéphane Picot; Mauricette Michallet; Philippe Vanhems
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

5.  Chemosensitization as a means to augment commercial antifungal agents.

Authors:  Bruce C Campbell; Kathleen L Chan; Jong H Kim
Journal:  Front Microbiol       Date:  2012-02-29       Impact factor: 5.640

Review 6.  Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).

Authors:  Can Boğa; Zahit Bolaman; Seçkin Çağırgan; İhsan Karadoğan; Mehmet Ali Özcan; Fahir Özkalemkaş; Rabin Saba; Mehmet Sönmez; Esin Şenol; Hamdi Akan; Murat Akova
Journal:  Turk J Haematol       Date:  2015-06       Impact factor: 1.831

Review 7.  Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.

Authors:  L Drgona; A Khachatryan; J Stephens; C Charbonneau; M Kantecki; S Haider; R Barnes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-12       Impact factor: 3.267

8.  A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction.

Authors:  Mehmet Özen; Gülden Yılmaz; Belgin Coşkun; Pervin Topçuoğlu; Bengi Öztürk; Mehmet Gündüz; Erden Atilla; Önder Arslan; Muhit Özcan; Taner Demirer; Osman İlhan; Nahide Konuk; İsmail Balık; Günhan Gürman; Hamdi Akan
Journal:  Turk J Haematol       Date:  2014-05-21       Impact factor: 1.831

9.  Monitoring of clinical strains and environmental fungal aerocontamination to prevent invasive aspergillosis infections in hospital during large deconstruction work: a protocol study.

Authors:  Sophie Tiphaine Loeffert; Elise Melloul; Cédric Dananché; Laetitia Hénaff; Thomas Bénet; Pierre Cassier; Damien Dupont; Jacques Guillot; Françoise Botterel; Martine Wallon; Marie-Paule Gustin; Philippe Vanhems
Journal:  BMJ Open       Date:  2017-11-25       Impact factor: 2.692

10.  Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study.

Authors:  Catherine Huoi; Philippe Vanhems; Marie-Christine Nicolle; Mauricette Michallet; Thomas Bénet
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.